Venue |
China Medical University, Taiwan view on map
No. 100, Sec. 1, Jingmao Rd, Beitun Dist,Taichung City 406040, Taiwan R.O.C.
|
Activity | Saturday, November 23, 2024 |
Registration period | Registration is open until November 16, 2024. (Registration) |
whether offering meal | November 23, 2024 lectures with lunch |
08:15 – 08:45 |
Registration |
08:45 – 09:00 |
Welcome messages: Dr. John S. Kuo, University Vice President, China Medical University Dr. Der-Yang Cho, Superintendent, China Medical University Hospital |
Group Photo | |
09:00 – 09:45 |
Kendall Lee, MD PhD (Mayo
Clinic, USA) – “Neuroengineering and Precision Surgery for Future Applications
and Neuropsychiatric Disorders”
|
09:45 – 10:30 |
Nader Pouratian, MD PhD (University of Texas-Southwestern Medical Center, USA) – “The Physiology of Disease and Brain Stimulation: Personalizing Neuromodulation from Parkinson Disease to Depression to Blindness” |
10:30 – 10:45 | Refreshment Break |
10:45 – 11:30
|
David Paydarfar, MD PhD (The University of Texas at Austin, USA) – “Beyond the Osler Limit Using Digital Twin Technology: Stroke and Next Generation Neurocritical Care” |
11:30 – 12:15 | Joe Chin-Chi Kuo, MD PhD (CMUH
Big Data Center) – “Moving from Medical Big Data to Systematic Digital Twins:
Advancing Integrative Clinical AI Development”
|
12:15 – 13:15 |
Lunch |
13:15 – 14:00 |
Alexander Khalessi, MD, MBA (University of California-San Diego, USA) – “Technical Gaps in Neurosurgery: Innovation in an Academic Ecosystem and the UC San Diego Experience” |
14:00 – 14:45 |
Jimmy Ming-Jung Chuang, MD
(Chang Gung Memorial Hospital, Kaohsiung, Taiwan) – “Current Applications of
VR/AR (Virtual Reality/Augmented Reality) in Complicated Neurosurgery and
Surgical Simulation”
|
14:45 – 15:00 |
Refreshment Break |
15:00 – 15:45 |
Yi-Wen Chen, PhD (CMUH
Research & Development Center for xDimensional Extracellular Vesicles) –
“Novel Strategy of HLA-G Targeted Exosome Platform for Drug-resistant Glioblastoma Treatment”
|
15:45 – 16:30
|
John S. Kuo, MD PhD (China
Medical University, Taiwan and The University of Texas at
Austin, USA) – “Surrounding and Targeting Glioblastoma via a
New Combination Immunotherapy Strategy”
|
16:30 – 16:45 |
Concluding Remarks
|